It's now active, alive, and incredibly vulnerable
Procurement organizations that had built formulary transition plans assuming rapid biosimilar adoption faced a specific problem: they had committed to biosimilar contracts that assumed market share conversions their formulary positioning could not achieve, because the rebate economics of the brand made preferred biosimilar positioning financially suboptimal for many intermediaries
And wherever youre listening, Apple or Spotify, click that subscribe button so you never miss an episode
The free fatty acid (FFA) levels were measured using commercial kits purchased from Randox Laboratories (Crumlin, Co., Antrim, UK)
GLP-1 RAs received FDA approval for the treatment of OSA in people with obesity, based on evidence that they reduce OSA severity through weight loss and potentially through direct effects on upper airway function